| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G |
| 13 Nov 2026 | SCHEDULE 13G |
| 13 Nov 2026 | SCHEDULE 13G |
| 09 Nov 2026 | 10-Q |
| 09 Nov 2026 |
8-K: Results of Operations and Financial Condition; Other Events
Announced positive topline 12-week Phase 1b results for ATTO-1310 in patients with chronic pruritus (CP) and high-itch atopic dermatitis (AD) |
| 08 Oct 2026 |
Form 4/A: Fu Tao, Director
Granted 538,300 Stock Option (Right to Buy) |
| 08 Oct 2026 |
Form 4/A: Chan Steven, Chief Financial Officer
Granted 140,000 Stock Option (Right to Buy) |
| 08 Oct 2026 |
Form 3/A: Fu Tao, Director
Holds 87,843 shares of Common Stock |
| 08 Oct 2026 | Form 3/A: Chan Steven, Chief Financial Officer |
| 02 Sep 2026 | 10-Q |
| 02 Sep 2026 |
8-K: Results of Operations and Financial Condition
ATTO-1310 demonstrated preliminary clinical proof of concept in chronic pruritus and high-itch atopic dermatitis (AD); complete Phase 1b data expected in Q4 2026 |
| 28 Aug 2026 | 144 |
| 28 Aug 2026 |
Form 4/A: Walsh Colin, Director
Bought 85,000 shares ($1.79M) · Sold 105,807 shares ($2.25M) · Acquired 105,807 Equity Swap (Open Market Purchase) ($2.25M) · 2 more |
| 28 Aug 2026 |
Form 4/A: Goldman Sachs Group Inc, Former 10% Owner and 7 others
Bought 85,000 shares ($1.79M) · Sold 105,807 shares ($2.25M) · Acquired 105,807 Equity Swap (Open Market Purchase) ($2.25M) · 2 more |
| 13 Aug 2026 |
Form 4: Walsh Colin, Director
Bought 85,000 shares ($1.79M) · Sold 105,807 shares ($2.25M) · Received 2,435,632 shares by conversion · 1 more |
| 13 Aug 2026 |
Form 4: Goldman Sachs Group Inc, Former 10% Owner and 7 others
Bought 85,000 shares ($1.79M) · Sold 105,807 shares ($2.25M) · Received 2,435,632 shares by conversion · 1 more |
| 12 Aug 2026 | SCHEDULE 13G |
| 11 Aug 2026 | SCHEDULE 13D |
| 10 Aug 2026 |
Form 4: venBio Global Strategic Fund IV, L.p., 10% owner
Received 3,799,015 shares by conversion · Bought 382,352 shares ($6.5M) |
| 10 Aug 2026 |
Form 4: Deep Track Biotechnology Master Fund, Ltd., 10% owner and 2 others
Received 1,957,138 shares by conversion |
Loading...